NMR Spectroscopy Machine Learning for Non-Invasive Cancer Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cancer detection methods, particularly for pancreatic ductal adenocarcinoma (PDAC) and non-small cell lung cancer (NSCLC), face challenges in sensitivity and specificity, especially in early-stage diagnosis, and existing AI-based imaging techniques are invasive, costly, and expose patients to radiation.
Innovation Solution
A machine learning system using nuclear magnetic resonance (NMR) spectroscopy of biofluids, such as blood plasma or serum, to detect hypermetabolic cancers by training a neural network with NMR spectra from normal and cancerous samples, allowing for non-invasive, rapid, and cost-effective cancer screening.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional imaging methods (CT, MRI) are used for cancer detection, then sensitivity and specificity can be improved, but the methods are invasive, costly, and expose patients to radiation
Solution Approach 1:
The patent replaces mechanical/radiological imaging systems (CT, MRI) with a chemical analysis system based on NMR spectroscopy. Instead of using ionizing radiation or strong magnetic fields to image anatomy, the system uses NMR to detect metabolic signatures in blood plasma, substituting a harmful physical imaging approach with a safer chemical analysis approach that measures molecular composition rather than anatomical structure
Solution Approach 2:
The patent introduces blood plasma as an intermediary medium for cancer detection. Rather than directly imaging the tumor or exposing tissue to radiation, the system analyzes metabolic byproducts circulating in the blood plasma, which serve as indirect markers of cancer presence. This intermediary approach allows detection of cancer metabolic signatures without direct contact with or exposure of the patient's body to harmful radiation
2Measurement precision
If AI-based imaging techniques are used for early cancer detection, then diagnostic accuracy improves, but the procedures become more complex and require specialized equipment
Solution Approach 1:
The patent extracts the diagnostic function from complex imaging equipment and relocates it to a simpler NMR spectrometer platform. By focusing on detecting metabolic signatures in blood plasma rather than attempting to image early-stage tumors directly, the system separates the essential detection function from the bulky, expensive imaging infrastructure, achieving comparable diagnostic accuracy with less complex equipment
Solution Approach 2:
The patent changes the detection parameter from anatomical/structural features (used in CT and MRI imaging) to metabolic/compositional features (detected by NMR spectroscopy). This parameter shift allows detection of cancer through biochemical signatures in blood plasma, which can be measured with simpler NMR equipment rather than requiring complex high-resolution imaging systems
3Ease of operation
If liquid biopsy methods are used for cancer detection, then non-invasive sampling is achieved, but sensitivity and specificity remain limited
Solution Approach 1:
The patent uses NMR spectroscopy to detect subtle changes in the metabolic 'color' or compositional profile of blood plasma. Instead of relying on the presence or absence of specific biomarkers, the system analyzes the overall metabolic fingerprint - the pattern of metabolite concentrations and ratios - which provides a more nuanced and accurate indication of cancer presence while maintaining the simplicity of blood sampling
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system achieves high sensitivity and specificity in distinguishing between normal, benign, and malignant conditions, providing accurate and reliable detection of PDAC and NSCLC without radiation exposure.
Implementation Method 1
Nuclear magnetic resonance ('NMR') spectroscopy is a spectroscopic technique that can be used to detect individual organic compounds in a chemical sample. The sample is exposed to a strong magnetic field and radio waves, and a nuclear magnetic resonance signal is produced, which is indicative of chemical compounds in the sample.
Data Source
AI summary
A computer-implemented machine learning system for, and method of, detecting a hypermetabolic cancer based on a nuclear magnetic resonance spectrum of a patient biofluid is presented. The techniques includes obtaining a nuclear magnetic resonance spectrum of a patient biofluid; providing the nuclear magnetic resonance spectrum to a machine learning system trained with a training corpus, the training corpus including a group of normal biofluid nuclear magnetic resonance spectra and a group of hypermetabolic cancer biofluid nuclear magnetic resonance spectra; and supplying an indication based on an output of the machine learning system, where the indication is representative of whether the nuclear magnetic resonance spectrum of the patient biofluid is indicative of cancer.